Singapore markets close in 2 hours 49 minutes
Straits Times Index
3,282.83 -4.92 (-0.15%) Nikkei
37,960.18 +331.70 (+0.88%) Hang Seng
17,728.60 +444.06 (+2.57%) FTSE 100
8,078.86 +38.48 (+0.48%) Bitcoin USD
64,487.85 +207.42 (+0.32%) CMC Crypto 200
1,392.39 -4.14 (-0.30%)
ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.36B |
| Enterprise value | 1.45B |
| Trailing P/E | 76.41 |
| Forward P/E | 14.31 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.43 |
| Price/book (mrq) | 3.15 |
| Enterprise value/revenue | 2.98 |
| Enterprise value/EBITDA | 13.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | 72.19% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 70.81 |
| 52-week low 3 | 37.06 |
| 50-day moving average 3 | 65.37 |
| 200-day moving average 3 | 58.68 |
Share statistics
| Avg vol (3-month) 3 | 145.38k |
| Avg vol (10-day) 3 | 116.81k |
| Shares outstanding 5 | 20.98M |
| Implied shares outstanding 6 | 20.98M |
| Float 8 | 15.09M |
| % held by insiders 1 | 11.20% |
| % held by institutions 1 | 75.97% |
| Shares short (15 Apr 2024) 4 | 213.52k |
| Short ratio (15 Apr 2024) 4 | 1.29 |
| Short % of float (15 Apr 2024) 4 | 1.32% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.02% |
| Shares short (prior month 15 Mar 2024) 4 | 261.6k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 18 Jul 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 3.86% |
| Operating margin (ttm) | 6.62% |
Management effectiveness
| Return on assets (ttm) | 3.72% |
| Return on equity (ttm) | 4.72% |
Income statement
| Revenue (ttm) | 486.82M |
| Revenue per share (ttm) | 27.04 |
| Quarterly revenue growth (yoy) | 39.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 109.32M |
| Net income avi to common (ttm) | 15.47M |
| Diluted EPS (ttm) | 0.85 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 221.12M |
| Total cash per share (mrq) | 11.22 |
| Total debt (mrq) | 291.34M |
| Total debt/equity (mrq) | 63.67% |
| Current ratio (mrq) | 3.57 |
| Book value per share (mrq) | 22.64 |
Cash flow statement
| Operating cash flow (ttm) | 118.96M |
| Levered free cash flow (ttm) | 112.78M |
© 2024 Yahoo. All rights reserved.